Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis

Immune checkpoint inhibitors, including cytotoxic T-lymphocyte antigen 4 (CTLA-4) and programmed cell death-1 (PD-1) inhibitors, represent an effective treatment modality for multiple malignancies. Despite the exciting clinical benefits, checkpoint inhibition is associated with a series of immune-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuzi, Sarah, Tavora, Fabio, Cruz, Marcelo, Costa, Ricardo, Chae, Young Kwang, Carneiro, Benedito A, Giles, Francis J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476791/
https://www.ncbi.nlm.nih.gov/pubmed/28652812
http://dx.doi.org/10.2147/CMAR.S136818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476791/
https://www.ncbi.nlm.nih.gov/pubmed/28652812
http://dx.doi.org/10.2147/CMAR.S136818

Ejemplares similares